PTC Therapeutics Inc (PTCT) Insider Trading

Total insider buys:
  • $31,673,582.00
Total insider sells:
  • $179,522,421.48
Most recent insider trade:
  • April 6, 2026
Most active insider trader:
  • Mark Elliott Boulding
Trader NameDateTitleAmountPriceTypeTotal Value
Nov. 3, 2020Insider6,194$56.50Sell$349,961.00
Nov. 2, 2020CEO50,000$53.66Sell$2,683,000.00
Oct. 16, 2020Director5,000$51.29Sell$256,450.00
Oct. 6, 2020CAO2,500$50.08Sell$125,200.00
Oct. 6, 2020CEO124,351$50.12Sell$6,232,472.12
July 15, 2020CEO100,000$55.70Sell$5,570,000.00
July 7, 2020VP30,625$55.12Sell$1,688,050.00
July 6, 2020CAO3,288$53.70Sell$176,565.60
June 29, 2020CFO2,581$52.50Sell$135,502.50
May 20, 2020CEO33,788$50.00Sell$1,689,400.00
May 5, 2020CEO109,928$50.34Sell$5,533,775.52
April 20, 2020Director17,900$51.04Sell$913,616.00
April 17, 2020Director2,100$50.16Sell$105,336.00
April 17, 2020CAO2,145$50.00Sell$107,250.00
April 3, 2020CAO787$44.31Sell$34,871.97
Jan. 23, 2020CEO423$53.25Sell$22,524.75
Jan. 23, 2020CFO330$53.25Sell$17,572.50
Jan. 23, 2020COO154$53.25Sell$8,200.50
Jan. 23, 2020Insider46$53.25Sell$2,449.50
Jan. 7, 2020CAO13,750$50.02Sell$687,775.00
Jan. 6, 2020Insider507$48.17Sell$24,422.19
Jan. 6, 2020CFO321$48.17Sell$15,462.57
Jan. 6, 2020COO86$48.17Sell$4,142.62
Jan. 6, 2020CEO1,797$48.17Sell$86,561.49
Dec. 3, 2019CEO22,463$49.43Sell$1,110,346.09
July 5, 2019VP15,312$44.74Sell$685,058.88
July 1, 2019SVP14,059$45.14Sell$634,623.26
July 1, 2019VP181,667$45.00Sell$8,175,015.00
June 28, 2019VP77,575$45.00Sell$3,490,875.00
June 28, 2019CAO988$45.00Sell$44,460.00
June 3, 2019COO5,490$40.38Sell$221,686.20
March 5, 2019Insider28,709$34.97Sell$1,003,953.73
Jan. 25, 2019Director66,225$30.20Buy$1,999,995.00
Jan. 7, 2019CEO2,512$34.75Sell$87,292.00
Jan. 7, 2019Insider297$34.75Sell$10,320.75
Jan. 7, 2019COO83$34.75Sell$2,884.25
June 19, 2018EVP20,000$48.31Sell$966,200.00
June 1, 2018COO5,161$34.65Sell$178,828.65
Jan. 5, 2018CEO2,230$18.03Sell$40,206.90
Jan. 4, 2018Insider412$17.67Sell$7,280.04
Jan. 4, 2018EVP77$17.67Sell$1,360.59
May 23, 2017Director25,000$13.49Buy$337,250.00
Jan. 5, 2017EVP78$11.82Sell$921.96
March 3, 2016Insider2,000$6.23Buy$12,460.00
July 6, 2015Director23,604$47.52Sell$1,121,662.08
June 18, 2015Director5,000$50.13Sell$250,650.00
June 9, 2015CEO100,000$54.49Sell$5,449,000.00
June 8, 2015Director7,000$55.66Sell$389,620.00
June 8, 2015VP56,849$55.04Sell$3,128,968.96
June 8, 2015CEO73,700$54.91Sell$4,046,867.00
  • Insiders are both buying and selling PTC Therapeutics Inc stock.

  • The insider traders at PTC Therapeutics Inc are: Mark Elliott Boulding, Stuart Walter Peltz, Christine Marie Utter, Neil Gregory Almstead, Emily Luisa Hill, Eric Pauwels, Matthew B Klein, Allan Steven Jacobson, Mark Rothera, Lee Scott Golden, Stephanie Okey, David P Southwell, Claudia De Oliveira Ri Hirawat, Pierre Gravier, Marcio Souza, Dawn Svoronos, Emma Reeve, Hbm Healthcare Investments (Ca, Jerome B Zeldis, Michael Schmertzler, Shane William Charles Kovacs, Alethia Young, Matthew B. Klein, Adam Koppel, Richard Aldrich, Robert J Spiegel, Robert Spiegel, David Southwell, Michael Kranda, and Michael L Kranda

  • The most active insider trader at PTC Therapeutics Inc is Mark Elliott Boulding with 34 trades.

  • Stuart Walter Peltz has sold the most PTC Therapeutics Inc stock with a total value of $85,044,720.20.

  • Adam Koppel has bought the most PTC Therapeutics Inc stock with a total value of $37,500,000.00.

  • The most recent insider trade for PTC Therapeutics Inc was on April 6, 2026.

  • The single biggest insider buy for PTC Therapeutics Inc was from Adam Koppel with a total value of $18,750,000.00 on June 25, 2013.

  • The single biggest insider sell for PTC Therapeutics Inc was from Stuart Walter Peltz with a total value of $21,253,437.00 on Dec. 7, 2020.